CELL AND GENE THERAPY CATAPULT
CELL AND GENE THERAPY CATAPULT is a pri/lbg/nsc (private, limited by guarantee, no share capital, use of 'limited' exemption) registered in the United Kingdom, under 10016023, incorporated on 19 February 2016. The company is currently active. Operates in the other professional, scientific and technical activities n.e.c. sector (SIC 74909). The company has been operating for 10 years. Registered office address: SE1 9RT London, the United Kingdom. Directors include MS DEBBIE DEE SWART and MR MATTHEW BRIAN DURDY. Shareholders include MR MATTHEW BRIAN DURDY and CELL THERAPY CATAPULT LIMITED. Associated with 7 related entities, including CELL THERAPY CATAPULT LIMITED, 09842382, and 10064526. The overall risk score is 0/100 (negligible). Confirmation statement next due 2026-02-17, overdue as of 2026-03-02. Data sourced from UK Companies House.
Official Identifiers
Registered Address
12TH FLOOR TOWER WING GUY'S HOSPITAL
GREAT MAZE POND
SE1 9RT LONDON
the United Kingdom
Entity Risk Evaluation
Signal Intelligence (1)
| Type | Severity | Description | Detected |
|---|---|---|---|
| confirmation statement overdue | MEDIUM | Confirmation statement next due 2026-02-17, overdue as of 2026-03-02 | — |
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (1)
| Date | Change | Details |
|---|---|---|
| 2026-04-28 | SECRETARY ADDED | Debbie Dee Swart (secretary) |
Source Records (1)
| companieshouse | 10016023 | 2026-06-01 | open_in_new |